Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
about
The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectivesCutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation.Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).Investigation of the molecular profile of basal cell carcinoma using whole genome microarraysVitamin D receptor expression and neoadjuvant therapy in esophageal adenocarcinomaVitamin D receptor and CD86 expression in the skin of vitamin D-deficient swine.Role of vitamin D metabolism in cutaneous tumour formation and progression.Vitamin D: metabolism, molecular mechanisms, and mutations to malignancies.Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.Overexpression of CXCL16 in lesional psoriatic skin.Analysis of the vitamin D system in cutaneous squamous cell carcinomas.Vitamin D receptor expression in the mucosal tissue at the gastroesophageal junction.The disintegrin-metalloproteinases ADAM 10, 12 and 17 are upregulated in invading peripheral tumor cells of basal cell carcinomas.Hair-cycle dependent differential expression of ADAM 10 and ADAM 12: An immunohistochemical analysis in human hair follicles in situ.An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes.Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm.Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study.
P2860
Q27004135-7443C84F-3576-4DDD-90A7-53ED12124F03Q33718913-CF453F63-5EB1-44B8-ADB8-7DF13A9275D6Q34460037-25598892-4E7A-440A-BD58-DF11A3CC5992Q35589231-D1DD858E-61B7-42C5-A9F9-6CC996BD86A2Q36105064-D6676421-23AC-4765-BA75-5ECE3B1EDB08Q37598688-DE0F0A11-8C40-4619-B13C-FB53825AA0ECQ38065197-0635DC3D-381E-4C48-ACCE-64E3F5CB4F0FQ38077504-39B88828-3FF4-4CB6-A95B-13C3F22E939FQ38905499-98010D5D-C210-4081-84E4-EC1D4BA7844AQ39533961-BB4337C9-4D7C-43F1-86EC-0886572DB13FQ40585780-F8F579E8-BE48-4CD8-A727-6D74783808DFQ42260716-DE204DFE-7D30-4061-A7F0-C4AE35804225Q42450718-59CE7A6D-53FD-49AE-B5AF-7D02676554B8Q42465242-F60B6888-16F7-44F9-B953-AC37E1987979Q42491089-1294FF4E-4974-4F8A-974B-DAEAD01F401EQ48111482-9E75185E-9059-450F-9656-F94E704AFBE2Q52917310-F657FA33-3134-4678-A316-85F330F1E710
P2860
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
@ast
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
@en
type
label
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
@ast
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
@en
prefLabel
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
@ast
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
@en
P2093
P2860
P1476
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65153-X
P407
P577
1999-08-01T00:00:00Z